Skip to main content
Search
Main content
News

Nine UK DRI researchers feature on Highly Cited Researcher 2022 list

We are proud to announce that nine UK DRI researchers have featured in this year’s Highly Cited Researcher 2022 list from Clarivate. The annual ranking identifies researchers who have demonstrated significant influence in their chosen field or fields through the publication of multiple highly cited papers during the last decade.

The 2022 list recognises 6938 researchers from more than 70 countries, whose citation records position them in the very highest strata of influence and impact. The UK is third on the world rankings with 579 researchers included this year.

The methodology that determines the “who’s who” of influential researchers is based on publications that rank in the top 1% by citations for field and publication year in the Web of Science™ citation index. Analysis is performed by bibliometric experts and data scientists at the Institute for Scientific Information™ at Clarivate. It also uses the tallies to identify the countries and research institutions where these scientific elite are based.

The nine researchers recognised from UK DRI are:

Prof David Rubinsztein

Group Leader & Interim Centre Director, UK DRI at Cambridge
Identification of novel pathways that induce autophagy to enable neuroprotection

David Sharp
Prof David Sharp

Centre Director, UK DRI Care Research & Technology
Cognition and Behaviour

Axel Montagne
Dr Axel Montagne

Group Leader, UK DRI at Edinburgh
Cerebrovascular and inflamm-ageing link to neurodegeneration and dementia

Prof Josef Priller

Group Leader, UK DRI at Edinburgh
Myeloid cells in neurodegenerative diseases

Tara Spires-Jones
Prof Tara Spires-Jones

Group Leader, UK DRI at Edinburgh
Non-cell autonomous mechanisms of synapse pathology

Prof Joanna Wardlaw

Group Leader, UK DRI at Edinburgh
Small vessel disease and vascular contributions to neurodegeneration and dementia

Bart De Strooper
Prof Bart De Strooper

UK DRI Director & Group Leader at UK DRI at UCL
Investigating the cellular reaction to amyloid beta and tau

Prof Nick Fox

Group Leader, UK DRI at UCL
From Patient to Bench and Back: Clinical Resources, Accelerating Therapies

Prof John Hardy

Group Leader, UK DRI at UCL
Analysis of neurodegeneration

Article published: 15 November 2022